Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 225-233

  Anderson, Karen L ^a   Itzhak, Yossef ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Methamphetamine; Neurotoxicity; Nitrate; Nitric oxide (NO); Nitrite; Peroxynitrite; Serotonin

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; NITRATE; NITRIC OXIDE; NITRITE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SEROTONIN; SEROTONIN TRANSPORTER;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING SITE; BRAIN REGION; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG EXPOSURE; DRUG MEGADOSE; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MOUSE; MOUSE STRAIN; NERVE CELL LESION; NERVE ENDING; NEUROTOXICITY; NONHUMAN; SEROTONIN UPTAKE;

EID: 33749541941     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.021     Document Type: Conference Paper

References (38)

1. KOGAN, F.J., W.K. NICHOLS & J.W. GIBB. 1976. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36: 363-371.
2. SEIDEN, L.S., M.W. FISCHMAN & C.R. SCHUSTER. 1976. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1: 215-219.
3. AXT, K.J. & M.E. MOLLIVER. 1991. Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9: 302-313.
4. GIBB, J.W., M. JOHNSON & G.R. HANSON. 1990. Neurochemical basis of neurotoxicity. NeuroToxicol. 11: 317-322.
5. RICAURTE, G.A., R.W. GUILLERY, L.S. SEIDEN, et al. 1982. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235: 93-103.
6. SEIDEN, L.S. & K.E. SABOL. 1996. Methamphetamine and methylene-dioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res. Monogr. 163: 251-276.
7. JOHNSON, E.A., J.P. O'CALLAGHAN & D.B. MILLER. 2002. Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse. Brain Res. 933: 130-138.
8. O'CALLAGHAN, J.P. & D.B. MILLER. 1994. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270: 741-751.
9. SHENG, P., C. CERRUTI & J.L. CADET. 1994. Methamphetamine (METH) causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide. Life Sci. 55: PL51-54.
10. CADET, J.L., S. JAYANTHI & X. DENG. 2003. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 17: 1775-1788.
11. ITZHAK, Y. & C. ACHAT-MENDES. 2004. Methamphetamine and MDMA (ecstasy) neurotoxicity: Of mice and men.' IUBMB Life 56: 249-255.
12. VOLKOW, N.D., L. CHANG, G.J. WANG, et al. 2001. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21: 9414-9418.
13. VOLKOW, N.D., L. CHANG, G.J. WANG, et al. 2001. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158: 377-382.
14. MCCANN, U.D., D.F. WONG, F. YOKOI, et al. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 18: 8417-8422.
15. MOSZCZYNSKA, A., P. FITZMAURICE, L. ANG, et al. 2004. Why is parkinsonism not a feature of human methamphetamine users? Brain 127: 363-370.
16. MCCANN, U.D. & G.A. RICAURTE. 2004. Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci. Biobehav. Rev. 27: 821-826.
17. BECKMAN, J.S., T.W. BECKMAN, J. CHEN, et al. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
18. ITZHAK, Y. & S.F. ALI. 2006. Role of nitrergic system in the behavioral and neurotoxic effects of amphetamine analogs. Pharmacol. Ther. 109: 246-262.
19. DI MONTE, D.A., I.E. ROYLAND, M.W. JAKOWEC & J.W. LANGSTON. 1996. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J. Neurochem. 67: 2443-2450.
20. ITZHAK, Y. & S.F. ALI. 1996. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67: 1770-1773.
21. ITZHAK, Y., J.L. MARTIN & S.F. ALI. 2000. nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice. Neuroreport 11: 2943-2946.
22. ITZHAK, Y., C. GANDIA, P.L. HUANG & S.F. ALI. 1998. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 284: 1040-1047.
23. IMAM, S.Z., J.P. CROW, G.D. NEWPORT, et al. 1999. Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst. Brain Res. 837: 15-21.
24. IMAM, S.Z. & S.F. ALI. 2000. Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res. 855: 186-191.
25. IMAM, S.Z., G.D. NEWPORT, Y. ITZHAK, et al. 2001. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J. Neurochem. 76: 745-749.
26. ITZHAK, Y., S.F. ALI, C.N. ACHAT & K.L. ANDERSON. 2003. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice. Psychopharmacol. 166: 241-248.
27. KUHN, D.M., C.W. ARETHA & T.J. GEDDES. 1999. Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration. J. Neurosci. 19: 10289-10294.
28. PARK, S.U., J.V. FERRER, J.A. JAVITCH & D.M. KUHN. 2002. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 22: 4399-4405.
29. LA VOIE, M.J. & T.G. HASTINGS. 1999. Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J. Neurochem. 73: 2546-2554.
30. GOTTI, S., M. SICA, C. VIGLIETTI-PANZICA & G. PANZICA. 2005. Distribution of nitric oxide synthase immunoreactivity in the mouse brain. Microsc. Res. Tech. 68: 13-35.
31. FUJIYAMA, F. & S. MASUKO. 1996. Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry. Brain Res. Bull. 40: 121-127.
32. MORRIS, B.J., C.S. SIMPSON, S. MUNDELL, et al. 1997. Dynamic changes in NADPH-diaphorase staining reflect activity in nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release. Neuropharmacology 36: 1589-1599.
33. CENTONZE, D., E. BRACCI, A. PISANI, et al. 2002. Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. Eur. J. Neurosci. 15: 2049-2052.
34. WANG, J.Q. & Y.-S. LAU. 2001. Dose-related alteration in nitric oxide synthase mRNA expression induced by amphetamine and the full D1 dopamine receptor agonist SKF-82958 in mouse striatum. Neurosci. Lett. 311: 5-8.
35. LIN, H.-C., B.-H. KANG, C.-S. WONG, et al. 1999. Systemic administration of D-amphetamine induced a delayed production of nitric oxide in the striatum of rats. Neurosci Lett 276: 141-144.
36. DE VENTE, J., M. MARKERINK-VAN ITTERSUM, J. VAN ABEELEN, et al. 2000. NO-mediated cGMP synthesis in cholinergic neurons in the rat forebrain: effects of lesioning dopaminergic or serotonergic pathways on nNOS and cGMP synthesis. Eur. J. Neurosci 12: 507-519.
37. GOMEZ, M.Z. & E.A. DEL BEL. 2003. Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase. Brain Res. Bull. 62: 107-115.
38. CARRETERO, J., E. WERUAGA, E. HERNANDEZ, et al. 2003. Dopaminergic modulation of nNOS expression in the pituitary gland of the rat. Anat. Embryol. 207: 381-388.